Key result
Same-day discharge after uncomplicated, minimalist TAVR was safe, with no 30-day mortality and similar rates of cardiovascular readmission (0% vs 5.5%, P=0.35) compared to next-day discharge.
Why the study?
While next-day discharge following minimalist TAVR is safe and feasible, there is a paucity of data regarding the safety, efficacy, and feasibility of same-day discharge.
Does a same-day discharge pathway maintain safety and efficacy compared to next-day discharge in selected patients undergoing uncomplicated, minimalist TAVR?
Population
Twenty nine SDD patients and 128 NDD patients meeting pre-specified SDD criteria after minimalist TAVR
Comparison
Same-day discharge pathway vs next-day discharge
Design
Single-center observational cohort study
Follow-up
30 days
Authors
Loading...
May support SDD after selected minimalist TAVR; hypothesis-generating and requires randomized trials before practice change.
Cohort (n=157)
No
Does a same-day discharge pathway maintain safety and efficacy compared to next-day discharge in selected patients undergoing uncomplicated, minimalist TAVR?
Absolute Event Rate: 0% vs 5.5%
p-value: p=0.35
Same-day discharge following uncomplicated, minimalist TAVR in carefully selected patients appears safe and feasible, yielding similar 30-day outcomes to next-day discharge.
Perdoncin et al. (2020) conducted a cohort in Uncomplicated, minimalist TAVR (n=157). Same-day discharge vs. Next-day discharge was evaluated on Cardiovascular readmission at 30 days (p=0.35). Same-day discharge after uncomplicated, minimalist TAVR was safe, with no 30-day mortality and similar rates of cardiovascular readmission (0% vs 5.5%, P=0.35) compared to next-day discharge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: